Ceramide-1-phosphate regulates migration of multipotent stromal cells and endothelial progenitor cells - Implications for tissue regeneration

Stem Cells

Volumn 31, Issue 3, 2013, Pages 500-510

  Kim, Chihwa ^a   Schneider, Gabriela ^a   Abdel Latif, Ahmed ^b   Mierzejewska, Kasia ^a,c   Sunkara, Manjula ^b   Borkowska, Sylwia ^a,c   Ratajczak, Janina ^a,c   Morris, Andrew J ^b   Kucia, Magda ^a,c   Ratajczak, Mariusz Z ^a,c  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Angiogenesis; Ceramide 1 phosphate; Chemotaxis; Human umbilical vein endothelial cell; Multipotent stromal cell

Indexed keywords

CERAMIDE 1 PHOSPHATE; CYCLOOXYGENASE 2; MATRIGEL; MESSENGER RNA; STROMAL CELL DERIVED FACTOR 1;

ANGIOGENESIS; ARTICLE; BONE MARROW CELL; CELL ASSAY; CELL ISOLATION; CELL MIGRATION; COLONY FORMING UNIT; CONTROLLED STUDY; EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FIBROBLAST; GENE EXPRESSION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STROMA CELL; TISSUE INJURY; TISSUE REGENERATION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; VASCULARIZATION; VERY SMALL EMBRYONIC LIKE STEM CELL; WESTERN BLOTTING;

ANIMALS; CELL GROWTH PROCESSES; CELL MOVEMENT; CERAMIDES; CHEMOTACTIC FACTORS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; MYOCARDIAL ISCHEMIA; REGENERATION; REGENERATIVE MEDICINE; STEM CELLS; UP-REGULATION;

EID: 84874855328     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1291     Document Type: Article

References (76)

1. Ortiz LA, Gambelli F, McBride C et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 2003; 100: 8407-8411.
2. Ortiz LA, DuTreil M, Fattman C et al. Interleukin 1 receptor antagonist mediates the anti-inflammatory and anti-fibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci USA 2007; 104: 11002-11007.
3. Kunter U, Rong S, Djuric Z et al. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. J Am Soc Nephrol 2006;17: 2202-2212.
4. Lee RH, Seo MJ, Reger RL et al. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic pancreatic islets and renal glomeruli in diabetic NOD/SCID mice. Proc Natl Acad Sci USA 2006;103: 17438-17443.
5. Ringden O, Uzunel M, Rasmusson L et al. Mesenchymal stem cells for the treatment of therapy-resistant graft-versus-host disease. Transplantation 2006;81: 1390-1397.
6. Minguell JJ, Erices A. Mesenchymal stem cells and the treatment of cardiac disease. Exp Biol Med (Maywood) 2006;231: 39-49.
7. Phinney DG, Isakova I. Plasticity and therapeutic potential of mesenchymal stem cells in the nervous system. Curr Pharm Des 2005;11: 1255-1265.
8. Dome B, Timar J, Dobos J et al. Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer. Cancer Res 2006;66: 7341-7347.
9. Gao D, Nolan DJ, Mellick AS et al. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 2008; 319: 195-198.
10. Gao D, Nolan D, McDonnell K et al. Bone marrow-derived endothelial progenitor cells contribute to the angiogenic switch in tumor growth and metastatic progression. Biochim Biophys Acta 2009;1796: 33-40.
11. Ratajczak MZ, Liu R, Ratajczak J et al. The role of pluripotent embryonic- like stem cells residing in adult tissues in regeneration and longevity. Differentiation 2011;81: 153-161.
12. Zuba-Surma EK, Wojakowski W, Ratajczak MZ et al. Very small embryonic- like stem cells: Biology and therapeutic potential for heart repair. Antioxid Redox Signal 2011;15: 1821-1834.
13. Wojakowski W, Kucia M, Liu R et al. Circulating very small embryonic- like stem cells in cardiovascular disease. J Cardiovasc Transl Res 2011;4: 138-144.
14. Drukałla J, Paczkowska E, Kucia M et al. Stem cells, including a population of very small embryonic-like stem cells, are mobilized into peripheral blood in patients after skin burn injury. Stem Cell Rev 2012; 8: 184-194.
15. Bruno S, Grange C, Deregibus MC et al. Mesenchymal stem cellderived microvesicles protect against acute tubular injury. J Am Soc Nephrol 2009;20: 1053-1067.
16. Herrera MB, Fonsato V, Gatti S et al. Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats. J Cell Mol Med 2010;14: 1605-1618.
17. Haynesworth SE, Baber MA, Caplan AI. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: Effects of dexamethasone and il-1 alpha. J Cellular Physiol 1996;166: 585-592.
18. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006;98: 1076-1084.
19. Majka M, Janowska-Wieczorek A, Ratajczak J et al. Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood 2001;97: 3075-3085.
20. Hanel P, Andre'ani P, Graler MH. Erythrocytes store and release sphingosine 1-phosphate in blood. FASEB J 2007;21: 1202-1209.
21. Ohkawa R, Nakamura K, Okubo S et al. Plasma sphingosine-1-phosphate measurement in healthy subjects: Close correlation with red blood cell parameters. Ann Clin Biochem 2008;45: 356-363.
22. Fyrst H, Saba JD. An update on sphingosine-1-phosphate and other sphingolipid mediators. Nat Chem Biol 2010;6: 489-497.
23. Ratajczak MZ, Lee H, Wysoczynski M et al. Novel insight into stem cell mobilization-plasma sphingosine-1-phosphate is a major chemoattractant that directs the egress of hematopoietic stem progenitor cells from the bone marrow and its level in peripheral blood increases during mobilization due to activation of complement cascade/membrane attack complex. Leukemia 2010;24: 976-985.
24. Li C, Kong Y, Wang H et al. Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis. J Hepatol 2009;50: 1174-1183.
25. Ratajczak J, Kucia M, Mierzejewska K et al. A novel view of paroxysmal nocturnal hemoglobinuria pathogenesis: More motile PNH hematopoietic stem/progenitor cells displace normal HSPCs from their niches in bone marrow due to defective adhesion, enhanced migration and mobilization in response to erythrocyte-released sphingosine-1 phosphate gradient. Leukemia 2012;26: 1722-1725.
26. Calise S, Blescia S, Cencetti F et al. Sphingosine 1-phosphate stimulates proliferation and migration of satellite cells: Role of S1P receptors. Biochim Biophys Acta 2012;1823: 439-450.
27. Ratajczak MZ, Kim CH, Abdel-Latif A et al. A novel perspective on stem cell homing and mobilization: Review on bioactive lipids as potent chemoattractants and cationic peptides as underappreciated modulators of responsiveness to SDF-1 gradients. Leukemia 2012;26: 63-72.
28. Arana L, Gangoiti P, Ouro A et al. Ceramide and ceramide 1-phosphate in health and disease. Lipids Health Dis 2010;9: 15.
29. Kim CH, Wu W, Wysoczynski M et al. Conditioning for hematopoietic transplantation activates the complement cascade and induces a proteolytic environment in bone marrow: A novel role for bioactive lipids and soluble C5b-C9 as homing factors. Leukemia 2012;26: 106-116.
30. Gomez-Munoz A, Kong JY, Parhar K et al. Ceramide-1-phosphate promotes cell survival through activation of the phosphatidylinositol 3-kinase/protein kinase B pathway. FEBS Lett 2005;579: 3744-3750.
31. Tsuji K, Mitsutake S, Yokose U et al. Role of ceramide kinase in peroxisome proliferator-activated receptor beta-induced cell survival of mouse keratinocytes. FEBS J 2008;275: 3815-3826.
32. Granado MH, Gangoiti P, Ouro A et al. Ceramide 1-phosphate (C1P) promotes cell migration Involvement of a specific C1P receptor. Cell Signal 2009;21: 405-412.
33. Gangoiti P, Bernacchioni C, Donati C et al. Ceramide 1-phosphate stimulates proliferation of C2C12 myoblasts. Biochimie 2012;94: 597-607.
34. Rivera J, Proia RL, Olivera A. The alliance of sphingosine-1-phosphate and its receptors in immunity. Nat Rev Immunol 2008;8: 753-763.
35. Niwa S, Graf C, Bornancin F. Ceramide kinase deficiency impairs microendothelial cell angiogenesis in vitro. Microvasc Res 2009;77: 389-393.
36. Majka M, Kijowski J, Lesko E et al. Evidence that platelet-derived microvesicles may transfer platelet-specific immunoreactive antigens to the surface of endothelial cells and CD34+ hematopoietic stem/progenitor cells - Implication for the pathogenesis of immune thrombocytopenias. Folia Histochem Cytobiol 2007;45: 27-32.
37. Winkler IG, Sims NA, Pettit AR et al. Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. Blood 2010;116: 4815-4828.
38. Castro-Malaspina H, Gay RE, Resnick G et al. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 1980;56: 289-301.
39. Penn MS, Ellis S, Gandhi S et al. Adventitial delivery of an allogeneic bone marrow-derived adherent stem cell in acute myocardial infarction: Phase I clinical study. Circ Res 2012;110: 304-311.
40. Samper E, Diez-Juan A, Montero JA et al. Cardiac cell therapy: Boosting mesenchymal stem cells effects. Stem Cell Rev 2012. DOI 10.1007/s12015-012-9353- z.
41. Zheng H, Fu G, Dai T et al. Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1alpha/CXCR4 via PI3K/Akt/eNOS signal transduction pathway. J Cardiovasc Pharmacol 2007;50: 274-280.
42. Ryu CH, Park SA, Kim SM et al. Migration of human umbilical cord blood mesenchymal stem cells mediated by stromal cell-derived factor- 1/CXCR4 axis via Akt, ERK, and p38 signal transduction pathways. Biochem Biophys Res Commun 2010;398: 105-110.
43. Hammad SM, Pierce JS, Soodavar F et al. Blood sphingolipidomics in healthy humans: Impact of sample collection methodology. J Lipid Res 2010;51: 3074-3087.
44. Hoggatt J, Singh P, Sampath J et al. Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation. Blood 2009; 113: 5444-5455.
45. Ratajczak MZ, Zuba-Surma E, Kucia M et al. The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis. Leukemia 2006;20: 1915-1924.
46. Hoggatt J, Pelus LM. Eicosanoid regulation of hematopoiesis and hematopoietic stem and progenitor trafficking. Leukemia 2010;24: 1993-2002.
47. Borlongan CV. Bone marrow stem cell mobilization in stroke: A 'bonehead' may be good after all! Leukemia 2011;25: 1674-1686.
48. Rettig MP, Ansstas G, DiPersio JF. Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4. Leukemia 2012;26: 34-53.
49. Kim RH, Takabe K, Milstien S et al. Export and functions of sphingosine- 1-phosphate. Biochim Biophys Acta 2009;1791: 692-696.
50. Alvarez SE, Milstien S, Spiegel S. Autocrine and paracrine roles of sphingosine-1-phosphate. Trends Endocrinol Metab 2007;18: 300-307.
51. Jin ZQ, Zhang J, Huang Y et al. A sphingosine kinase 1 mutation sensitizes the myocardium to ischemia/reperfusion injury. Cardiovasc Res 2007;76: 41-50.
52. Jin ZQ, Karliner JS, Vessey DA. Ischaemic postconditioning protects isolated mouse hearts against ischaemia/reperfusion injury via sphingosine kinase isoform-1 activation. Cardiovasc Res 2008;79: 134-140.
53. Vessey DA, Li L, Jin ZQ et al. A sphingosine kinase form 2 knockout sensitizes mouse myocardium to ischemia/reoxygenation injury and diminishes responsiveness to ischemic preconditioning. Oxid Med Cell Longev 2011;2011: 961059.
54. Hannun YA, Obeid LM. The Ceramide-centric universe of lipid-mediated cell regulation: Stress encounters of the lipid kind. J Biol Chem 2002;277: 25847-25850.
55. Sanvicens N, Cotter TG. Ceramide is the key mediator of oxidative stress-induced apoptosis in retinal photoreceptor cells. J Neurochem 2006;98: 1432-1444.
56. Gómez-Muñoz A. Ceramide-1-phosphate: A novel regulator of cell activation. FEBS Lett 2004;562: 5-10.
57. Lapidot T, Dar A, Kollet O. How do stem cells find their way home? Blood 2005;106: 1901-1910.
58. Greenbaum AM, Link DC. Mechanisms of G-CSF-mediated hematopoietic stem and progenitor mobilization. Leukemia 2011;25: 211-217.
59. Mark AL, Sun Z, Warren DS et al. Stem cell mobilization is life saving in an animal model of acute liver failure. Ann Surg 2010;252: 591-596.
60. Yannaki E, Athanasiou E, Xagorari A et al. G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs. Exp Hematol 2005;33: 108-119.
61. Yannaki E, Psatha N, Athanasiou E et al. Mobilization of hematopoietic stem cells in a thalassemic mouse model: Implications for human gene therapy of thalassemia. Hum Gene Ther 2010;21: 299-310.
62. Gordon MY, Levicar N, Pai M et al. Characterization and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells 2006;24: 1822-1830.
63. Pasquet S, Sovalat H, Hénon P et al. Long-term benefit of intracardiac delivery of autologous granulocyte-colony-stimulating factor-mobilized blood CD34+ cells containing cardiac progenitors on regional heart structure and function after myocardial infarct. Cytotherapy 2009;11: 1002-1015.
64. Zohlnhöfer D, Ott I, Mehilli J et al. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: A randomized controlled trial. JAMA 2006;295: 1003-1010.
65. Malafronte C, Achilli F. Stem cells mobilization in acute myocardial infarction (stem-AMI trial): Preliminary data of a perspective, randomized, single blind trial. Minerva Cardioangiol 2007;55: 721-731.
66. George JC. Stem cell therapy in acute myocardial infarction: A review of clinical trials. Transl Res 2010;155: 10-19.
67. Ratajczak MZ. Spotlight series on stem cell mobilization: Many hands on the ball, but who is the quarterback? Leukemia 2010;24: 1665-1666.
68. Ioannidou E. Therapeutic modulation of growth factors and cytokines in regenerative medicine. Curr Pharm Des 2006;12: 2397-2408.
69. Ratajczak MZ, Kucia M, Jadczyk T et al. Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: Can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies? Leukemia 2012;26: 1166-1173.
70. Janowska-Wieczorek A, Wysoczynski M, Kijowski J et al. Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer 2005;113: 752-760.
71. Camussi G, Deregibus MC, Bruno S et al. Exosome/microvesicle-mediated epigenetic reprogramming of cells. Am J Cancer Res 2011;1: 98-110.
72. Camussi G, Cantaluppi V, Deregibus MC et al. Role of microvesicles in acute kidney injury. Contrib Nephrol 2011;174: 191-199.
73. Baj-Krzyworzeka M, Majka M, Pratico D et al. Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells. Exp Hematol 2002;30: 450-459.
74. Rüster B, Göttig S, Ludwig RJ et al. Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells. Blood 2006;108: 3938-3944.
75. Rafii S, Lyden D, Benezra R et al. Vascular and haematopoietic stem cells: Novel targets for anti-angiogenesis therapy? Nat Rev Cancer 2002;2: 826-835.
76. Casteilla L, Planat-Bénard V, Cousin B et al. Vascular and endothelial regeneration. Curr Stem Cell Res Ther 2010;5: 141-144.